无缝合主动脉瓣在单独与联合手术中的应用:784例患者十三年经验
本研究回顾性分析2007至2019年单中心784例使用Perceval无缝合瓣膜行主动脉瓣置换的患者,平均年龄78岁,中位欧洲心脏手术风险评估系统II评分4.2%。装置成功率为99.1%,院内死亡率为3.3%,术后卒中或短暂性脑缺血发作发生率为1.9%,1年、5年和10年免于再干预率分别为99%、97%和94%。
要点
- 装置成功率为99.1%,院内死亡率为3.3%,术后卒中或短暂性脑缺血发作发生率为1.9%。
- 单纯主动脉瓣置换占45%,联合冠状动脉旁路移植术占30%,其他联合手术占25%。
- 中位生存时间为7.0年,1年、5年和10年免于再干预率分别为99%、97%和94%。
核心结论
- 这些数据代表了据我们所知Perceval无缝合瓣膜最长的随访时间,早期结果良好,早期死亡率、卒中和其他主要并发症发生率低,瓣膜耐久性有前景,瓣膜退变率低且再干预需求有限。
研究设计与样本
- 回顾性分析2007年至2019年在鲁汶大学医院(UZ Leuven)接受Perceval无缝合主动脉瓣置换术(单独或联合其他手术)的784例患者的术后和随访数据。
主要发现
- 平均年龄为78岁,中位欧洲心脏手术风险评估系统II评分为4.2%(四分位距2.6%-7.2%)。
- 单纯主动脉瓣置换占45%,主动脉瓣置换联合冠状动脉旁路移植术占30%,其他联合手术占25%。
- 中位主动脉阻断时间在单纯主动脉瓣置换中为38分钟,在联合冠状动脉旁路移植术病例中为70分钟,在多个瓣膜手术病例中为89分钟。
- 装置成功率为99.1%,院内死亡率为3.3%,术后卒中或短暂性脑缺血发作发生率为1.9%,术后新需要透析的患者为1%,中位生存时间为7.0年,累积随访2797.8患者年。
- 1年、5年和10年免于再干预率分别为99%、97%和94%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to evaluate the outcome and experience of the Perceval sutureless valve at our institution (UZ Leuven). METHODS: Between 2007 and 2019, 784 patients underwent sutureless aortic valve replacement using the Perceval valve (isolated or combined with other procedures). We performed a retrospective analysis of the postoperative and follow-up data. RESULTS: Mean age was 78 years with a median European System for Cardiac Operative Risk Evaluation II score of 4.2% (interquartile range, 2.6%-7.2%). Isolated aortic valve replacement accounted for 45% of cases; 30% of cases were aortic valve replacement in combination with coronary artery bypass grafting and the remaining 25% were other combined procedures. The median crossclamp times were 38 minutes in single aortic valve replacement, 70 minutes in cases with coronary artery bypass grafting, and 89 minutes in multiple valve cases. Device success was 99.1% and in-hospital mortality was 3.3%. Postoperative stroke or transient ischemic attack occurred in 1.9% of patients and 1% of patients had a new need for dialysis after surgery and median survival time was 7.0 years with a cumulative follow-up of 2797.8 patient-years. The 1-, 5-, and 10-year freedom from reintervention were 99%, 97%, and 94%, respectively. CONCLUSIONS: These data represent the longest follow-up available, to our knowledge, for the Perceval sutureless valve. We observed favorable early outcomes, and low rates of early mortality, stroke, and other major complications. Valve durability is promising with low rates of valve degeneration and a limited need for reintervention.
引用
- Lamberigts M, Szecel D, Rega F, et al. Sutureless aortic valves in isolated and combined procedures: Thirteen years of experience in 784 patients. J Thorac Cardiovasc Surg. 2022. PMID: 36404146. doi:10.1016/j.jtcvs.2022.09.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。